Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
暂无分享,去创建一个
Yan Yan | P. Humphrey | G. Andriole | Yan Yan | T. Bismar | Gerald L Andriole | Jason W Anast | Tarek A Bismar | Peter A Humphrey | J. Anast | Jason W. Anast
[1] Mesut Remzi,et al. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. , 2003, The Journal of urology.
[2] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[3] W. Catalona,et al. The nature of prostate cancer detected through prostate specific antigen based screening. , 1994, The Journal of urology.
[4] L. Baert,et al. Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view. , 1997, The Journal of urology.
[5] T. Stamey,et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. , 2001, The Journal of urology.
[6] P. Humphrey,et al. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. , 1996, The Journal of urology.
[7] M. Graefen,et al. Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction. , 2003, European urology.
[8] M. Terris,et al. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. , 1995, Urology.
[9] M W Kattan,et al. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. , 1996, The Journal of urology.
[10] P. Scardino,et al. Early detection of prostate cancer. , 1989, The Urologic clinics of North America.
[11] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[12] P. Humphrey,et al. Multiple Measures of Carcinoma Extent Versus Perineural Invasion in Prostate Needle Biopsy Tissue in Prediction of Pathologic Stage in a Screening Population , 2003, The American journal of surgical pathology.
[13] Yingdong Zhao,et al. Molecular Differentiation of High- and Moderate-Grade Human Prostate Cancer by cDNA Microarray Analysis , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[14] P. Humphrey,et al. Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population. , 2002, American journal of clinical pathology.
[15] D. Chan,et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.
[16] P. Humphrey,et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. , 1998, Urology.
[17] P. Walsh,et al. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. , 1997, Journal of Urology.
[18] M. Irwin,et al. Identification of insignificant prostate cancers: analysis of preoperative parameters. , 1994, Urology.
[19] P. Walsh,et al. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. , 2002, The Journal of urology.
[20] D. Bostwick,et al. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. , 1995, The Journal of urology.